Microtubule distribution in somatic cell nuclear transfer bovine embryos following control of nuclear remodeling type.
This study was conducted to evaluate the microtubule distribution following control of nuclear remodeling by treatment of bovine somatic cell nuclear transfer (SCNT) embryos with caffeine or roscovitine. Bovine somatic cells were fused to enucleated oocytes treated with either 5 mM caffeine or 150 microM roscovitine to control the type of nuclear remodeling. The proportion of embryos that underwent premature chromosome condensation (PCC) was increased by caffeine treatment but was reduced by roscovitine treatment (p < 0.05). The microtubule organization was examined by immunostaining beta- and gamma-tubulins at 15 min, 3 h, and 20 h of fusion using laser scanning confocal microscopy. The gamma-tubulin foci inherited from the donor centrosome were observed in most of the SCNT embryos at 15 min of fusion (91.3%) and most of them did not disappear until 3 h after fusion, regardless of treatment (82.9-87.2%). A significantly high proportion of embryos showing an abnormal chromosome or microtubule distribution was observed in the roscovitinetreated group (40.0%, p < 0.05) compared to the caffeinetreated group (22.1%). In conclusion, PCC is a favorable condition for the normal organization of microtubules, and inhibition of PCC can cause abnormal mitotic division of bovine SCNT embryos by causing microtubule dysfunction.
Kwon
Dae Jin
DJ
College of Veterinary Medicine and Institute of Veterinary Science, Kangwon National University, Chuncheon 200-701, Korea.
Lee
Yu Mi
YM
Hwang
In Sun
IS
Park
Choon Keun
CK
Yang
Boo Keun
BK
Cheong
Hee Tae
HT
D000818:Animals; D002110:Caffeine / Q000494:pharmacology; D002417:Cattle / Q000196:embryology / Q000502:physiology*; D002467:Cell Nucleus / Q000187:drug effects / Q000502:physiology* / Q000648:ultrastructure; D005260:Female; D005307:Fertilization in Vitro / Q000662:veterinary; D008297:Male; D018613:Microscopy, Confocal / Q000662:veterinary; D008870:Microtubules / Q000187:drug effects / Q000502:physiology* / Q000648:ultrastructure; D053652:Nuclear Transfer Techniques / Q000662:veterinary; D009865:Oocytes / Q000502:physiology*; D011247:Pregnancy; D011687:Purines / Q000494:pharmacology; D000077546:Roscovitine
D011687:Purines; D000077546:Roscovitine; D002110:Caffeine
J Cell Sci. 1996 Apr;109 ( Pt 4):875-87
8718679
Biol Reprod. 2002 Aug;67(2):442-6
12135879
Mol Reprod Dev. 2003 Apr;64(4):482-91
12589660
Annu Rev Biochem. 1994;63:639-74
7979251
Nature. 2002 Oct 10;419(6907):583-6
12374931
Nature. 1995 Dec 7;378(6557):578-83
8524390
Reproduction. 2008 May;135(5):649-56
18411411
Mol Reprod Dev. 2003 Mar;64(3):369-78
12548669
Mol Reprod Dev. 1994 Feb;37(2):138-45
8179897
Nature. 1998 Jul 23;394(6691):369-74
9690471
Biol Reprod. 1975 Mar;12(2):260-74
1122333
Cell Cycle. 2007 Jun 15;6(12):1510-20
17581281
Biol Reprod. 2000 Sep;63(3):715-22
10952912
Biol Reprod. 2003 Dec;69(6):1890-4
12904315
Exp Cell Res. 2005 May 15;306(1):35-46
15878330
Biol Reprod. 2003 Nov;69(5):1707-13
12890737
Cell. 1991 May 31;65(5):825-36
1840506
Mol Reprod Dev. 2002 May;62(1):74-82
11933163
Curr Opin Cell Biol. 1995 Feb;7(1):39-45
7755988
Biol Reprod. 1993 May;48(5):958-63
8481482
Biol Reprod. 1991 Sep;45(3):455-65
1782294
J Cell Biol. 1993 May;121(4):823-35
8491775
Trends Cell Biol. 1993 Apr;3(4):118-28
14731766
Biol Reprod. 2005 Feb;72(2):373-83
15469999
Biol Reprod. 2004 Dec;71(6):2022-8
15317686
Mol Reprod Dev. 2004 Nov;69(3):289-95
15349840
Biol Reprod. 2001 Jan;64(1):324-30
11133690
Biol Reprod. 2002 Sep;67(3):760-6
12193382
Reproduction. 2005 Feb;129(2):171-80
15695611
Reproduction. 2006 Jun;131(6):1051-61
16735544